Immunocore Holdings plc Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2022 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: Immunocore Holdings plc quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2022 to Q3 2024.
Immunocore Holdings plc Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending September 30, 2024 was $63.7M.

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$63.7M			Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$60.2M			Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$57.8M			Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$52.1M	+$18.5M	+55.1%	Dec 31, 2023	10-Q	2024-11-06
Q4 2022	$33.6M			Dec 31, 2022	10-K	2024-02-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.